None of these recommendations was based on clinical or epidemiological evidence, instead relying on the pathophysiological knowledge of the disease at the time, the pharmacological effect of medications, and good sense.
[…]
Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based Approach
Beck-da-SilvaL. Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based Approach. ABC Heart Fail Cardiomyop 2022;2(1):36-40.
Beck-da-Silva,Luís. Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based Approach. ABC Heart Fail Cardiomyop, v. 2, n. 1, p. 36-40, Apr. 2022.
Beck-da-Silva,L. (2022). Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based Approach. ABC Heart Fail Cardiomyop,2(1), 36-40.
Beck-da-Silva,Luís. Sequencing of Pharmacotherapy for Heart Failure with Reduced Ejection Fraction: A Clinical Profile-Based Approach. ABC Heart Fail Cardiomyop [online]. 2022, vol. 2, n. 1, [cited 2025-09-17], pp.36-40. Available from: <https://www.abcheartfailure.org/article/sequencing-of-pharmacotherapy-for-heart-failure-with-reduced-ejection-fraction-a-clinical-profile-based-approach/>. ISSN .